Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management-A Systematic Review

dc.contributor.authorDiaz, Michael Joseph
dc.contributor.authorAflatooni, Shaliz
dc.contributor.authorAbdi, Parsa
dc.contributor.authorLi, Rina
dc.contributor.authorRobert Anthony, Michelle
dc.contributor.authorNeelam, Sphurti
dc.contributor.authorFarkouh, Chris
dc.contributor.authorTran, Jasmine Thuy
dc.contributor.authorSvoboda, Steven
dc.contributor.authorForouzandeh, Mahtab
dc.contributor.authorValdes Rodriguez, Rodrigo H.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-01-03T13:14:00Z
dc.date.available2024-01-03T13:14:00Z
dc.date.issued2023-05-17
dc.description.abstractHidradenitis suppurativa is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with apocrine glands. The condition is characterized by recurrent, painful nodules, abscesses, and draining sinuses that can lead to scarring and disfigurement. In this present study, we provide a focused evaluation of recent developments in hidradenitis suppurativa research, including novel therapeutics and promising biomarkers that may facilitate clinical diagnosis and treatment. We conducted a systematic review of controlled trials, randomized controlled trials, meta-analyses, case reports, and Cochrane Review articles in accordance with the PRISMA guidelines. The Cochrane Library, PubMed, EMBASE, and Epistemonikos databases were queried via Title/Abstract screen. Eligibility criteria included the following: (1) has a primary focus on hidradenitis suppurativa, (2) includes measurable outcomes data with robust comparators, (3) details the sample population, (4) English language, and (5) archived as full-text journal articles. A total of 42 eligible articles were selected for review. Qualitative evaluation identified numerous developments in our understanding of the disease's multiple potential etiologies, pathophysiology, and treatment options. It is important for individuals with hidradenitis suppurativa to work closely with a healthcare provider to develop a comprehensive treatment plan that addresses their individual needs and goals. To meet this objective, providers must keep current with developments in the genetic, immunological, microbiological, and environmental factors contributing to the disease's development and progression.
dc.eprint.versionFinal published version
dc.identifier.citationDiaz MJ, Aflatooni S, Abdi P, et al. Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management-A Systematic Review. Curr Issues Mol Biol. 2023;45(5):4400-4415. Published 2023 May 17. doi:10.3390/cimb45050280
dc.identifier.urihttps://hdl.handle.net/1805/37570
dc.language.isoen_US
dc.publisherMDPI
dc.relation.isversionof10.3390/cimb45050280
dc.relation.journalCurrent Issues in Molecular Biology
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectAcne inversa
dc.subjectEtiology
dc.subjectHidradenitis suppurativa
dc.subjectPathophysiology
dc.subjectSystematic review
dc.subjectTreatment
dc.titleHidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management-A Systematic Review
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
cimb-45-00280.pdf
Size:
619.18 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: